ENGAGE-501: Phase II study of entinostat (SNDX-275) in relapsed and refractory hodgkin lymphoma

Connie Lee Batlevi, Yvette Kasamon, R. Gregory Bociek, Peter Lee, Lia Gore, Amanda Copeland, Rachel Sorensen, Peter Ordentlich, Scott Cruickshank, Lori Kunkel, Daniela Buglio, Francisco Hernandez-Ilizaliturri, Anas Younes

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'ENGAGE-501: Phase II study of entinostat (SNDX-275) in relapsed and refractory hodgkin lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry